Mouhannad Jumaa,Tony Muchamuel,Naveen Bejugam,Hansen Wong,Christopher J. Kirk,Rahul Vishram Manek,Sanjeev Sharma
申请号：
US15008634
公开号：
US20160213610A1
申请日:
2016.01.28
申请国别(地区):
US
年份:
2016
代理人:
摘要：
This disclosure features modified release pharmaceutical formulations (e.g., extended release pharmaceutical formulations； e.g., solid dosage forms, e.g., tablets) that are useful for the oral administration of oprozomib, or a pharmaceutically acceptable salt thereof, to a human or animal subject as well as methods of making and using the formulations.
